Skip to main content
logo
Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,384.00
+14.00 (1.02%)
Aug 12, 2026, 3:30 PM KST

Xcell Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
23,93528,72644,384---
Market Cap Growth
-37.39%-35.28%----
Enterprise Value
22,91633,87338,298---
Last Close Price
1384.001661.003373.54---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.0614.7422.95---
PB Ratio
3.664.024.87---
P/TBV Ratio
4.074.465.17---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.6817.3819.80---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.810.770.632.730.690.38
Net Debt / Equity Ratio
-0.16-0.20-0.342.160.03-0.52
Net Debt / EBITDA Ratio
0.110.160.40-0.70-0.041.80
Net Debt / FCF Ratio
0.090.140.42-0.73-0.031.42
Asset Turnover
0.180.120.140.090.050.10
Inventory Turnover
3.423.874.444.014.673.87
Quick Ratio
1.361.361.900.361.192.83
Current Ratio
1.881.812.140.521.392.93
Return on Equity (ROE)
-173.83%-134.41%-165.90%-170.80%-67.53%-102.65%
Return on Assets (ROA)
-48.15%-41.59%-42.63%-43.01%-26.46%-18.88%
Return on Capital Employed (ROCE)
-115.10%-104.40%-77.90%-177.90%-80.40%-30.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-47.24%-38.04%-21.50%---
FCF Yield
-45.24%-36.09%-16.63%---
Buyback Yield / Dilution
-26.67%-16.45%-13.14%-1.02%-5.71%-364.87%